After the substance is given intravenously, it accumulates in beta amyloid plaques in the patient's brain, which thus become visible via positron emission tomography (PET).
Flutemetamol 
Rimegepant
Methocarbamol
Disulfiram
Quazepam
Perphenazine
Camazepam
Cinolazepam